40 employees
Everlife Asia is a buy-and-build platform aimed to provide complete solutions for the healthcare and research industries.
$27M sweet spot round size
Most of their 1 investments are in rounds between $27M and $27M
2014
AUM Biosciences raised $27M on October 12, 2021
Investors: SPRIM Global, A*STAR - Agency for Science, Technology and Research and Everlife Asia